Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
Authors
Keywords
Antifibrotics, IPF, Lung transplantation, Nintedanib, Pirfenidone, Safety
Journal
BMC Pulmonary Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-18
DOI
10.1186/s12890-016-0308-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of the lung allocation score on lung transplantation in the United States
- (2016) Thomas M. Egan et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- The Utility of Preoperative Six-Minute-Walk Distance in Lung Transplantation
- (2015) Anthony W. Castleberry et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome—a single-centre experience
- (2015) Jonas Yserbyt et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
- (2015) Paul W. Noble et al. EUROPEAN RESPIRATORY JOURNAL
- Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis
- (2015) Steven D. Nathan et al. RESPIRATORY MEDICINE
- A Combined Therapeutic Approach in Progressive Idiopathic Pulmonary Fibrosis—Pirfenidone as Bridge Therapy for Ex Vivo Lung Transplantation: A Case Report
- (2015) G. Paone et al. TRANSPLANTATION PROCEEDINGS
- Nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Mariano E. Mazzei et al. Therapeutic Advances in Respiratory Disease
- Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
- (2014) Enrico Conte et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- P242 Pirfenidone As A Bridge To Lung Transplantation In Patients With Progressive Ipf
- (2014) P. Riddell et al. THORAX
- Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
- (2014) Kristin D Kistler et al. BMC Pulmonary Medicine
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started